Case Studies
VOC biomarkers – a novel approach to early detection, precision medicine and drug development, that’s already bearing fruit
Across the world, leading breath researchers are breaking ground establishing new clinical and pharmaceutical applications for VOC biomarkers, with much of the most exciting work underpinned by our Breath Biopsy and FAIMS technologies.
These case studies, many of which are from our academic and clinical partners, explore the untapped potential of VOCs across a wide range of disease areas.
There are a virtually unlimited range of applications across early detection and precision medicine for illnesses including respiratory diseases, cancer, gastrointestinal and cardiometabolic disease, as well as exposomics. Contact us to discuss how you can add breath research to your own research.
VOC biomarkers indicative of Eosinophilic Inflammation in Asthma
Biomarker Predictors of Omalizumab Efficacy in Asthma
Breath Analysis for C. diff Infection Diagnosis
Breath VOC biomarkers for infectious diseases
Discover the link between SIBO and Rosacea
Breath Analysis for Diagnosing Viral Infections in COPD
Breath VOC biomarkers for Asthma: where are we at in 2024?
VOCs reflect physiological changes in ultramarathon runners
Breath biomarkers show potential for diagnosing and staging kidney disease
Learn about breath biomarkers and their applications. Download our free ebook.
